Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Certara, Inc. - Common Stock (NQ:CERT)

9.670 +0.180 (+1.90%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,452,601
Open 9.500
Bid (Size) 9.400 (100)
Ask (Size) 9.650 (1,100)
Prev. Close 9.490
Today's Range 9.380 - 9.870
52wk Range 8.025 - 15.69
Shares Outstanding 159,831,701
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Certara’s Volatility: From a 23% Earnings Plunge to a $3 Million Institutional Vote of Confidence
The biosimulation market was sent into a tailspin in the closing months of 2025 as Certara (Nasdaq:CERT), a global leader in model-informed drug development, saw its market valuation crater by 23%. The... 
Via MarketMinute
Topics Earnings
News headline image
Certara Stock Fell 23% After Earnings and This Fund Bought Up $3 Million Anyway ↗
Certara provides biosimulation software and regulatory solutions to global biopharma clients, supporting drug development and approvals. 
Via The Motley Fool

Performance

YTD
+10.6%
+10.6%
1 Month
+6.4%
+6.4%
3 Month
-25.6%
-25.6%
6 Month
-15.7%
-15.7%
1 Year
-13.9%
-13.9%

More News

Read More
News headline image
Certara Appoints Jon Resnick as Chief Executive Officer
From Certara
Via GlobeNewswire
News headline image
Earnings Scheduled For November 6, 2025 ↗
Via Benzinga
News headline image
Earnings Scheduled For August 6, 2025 ↗
Via Benzinga
News headline image
Healthcare AI Exits Pilot Phase, Enters Production Deployment
From Equity Insider
Via GlobeNewswire
News headline image
ArrowMark Slashes Alight Position Amid Growing Questions About Its Recurring-Revenue Strategy ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
The Next Wave Of AI Winners? Investors Shift Focus Beyond Nvidia ↗
Via Benzinga
Topics Artificial Intelligence
News headline image
Certara Reports Third Quarter 2025 Financial Results
From Certara
Via GlobeNewswire
News headline image
Certara Automates Scientific Workflows with Phoenix® Cloud
From Certara
Via GlobeNewswire
News headline image
Certara to Participate in Upcoming Investor Conferences
From Certara
Via GlobeNewswire
News headline image
Certara Expands Biosimulation Market with AI-Driven QSP Platform
From Certara
Via GlobeNewswire
News headline image
Certara Scientists are Among the Topmost Cited Biopharma Researchers
From Certara
Via GlobeNewswire
News headline image
Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025
From Certara
Via GlobeNewswire
News headline image
Beyond The Numbers: 4 Analysts Discuss Certara Stock ↗
Via Benzinga
News headline image
RH Posts Downbeat Results, Joins Frequency Electronics, Tronox And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
Via Benzinga
News headline image
Certara Launches Pinnacle 21® Enterprise Plus to Deliver Regulatory Submissions Faster
From Certara
Via GlobeNewswire
News headline image
Certara to Participate in Upcoming Investor Conferences
From Certara
Via GlobeNewswire
News headline image
Certara (CERT) Q2 Revenue Jumps 12% ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Certara Reports Second Quarter 2025 Financial Results
From Certara
Via GlobeNewswire
News headline image
Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling
From Certara
Via GlobeNewswire
News headline image
Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform
From Certara
Via GlobeNewswire
News headline image
Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025
From Certara
Via GlobeNewswire
News headline image
Certara Announces Expansion of Clinical Technology Collaboration with Merck
From Certara
Via GlobeNewswire
News headline image
What Analysts Are Saying About Certara Stock ↗
Via Benzinga

Frequently Asked Questions

Is Certara, Inc. - Common Stock publicly traded?
Yes, Certara, Inc. - Common Stock is publicly traded.
What exchange does Certara, Inc. - Common Stock trade on?
Certara, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Certara, Inc. - Common Stock?
The ticker symbol for Certara, Inc. - Common Stock is CERT on the Nasdaq Stock Market
What is the current price of Certara, Inc. - Common Stock?
The current price of Certara, Inc. - Common Stock is 9.670
When was Certara, Inc. - Common Stock last traded?
The last trade of Certara, Inc. - Common Stock was at 01/08/26 04:00 PM ET
What is the market capitalization of Certara, Inc. - Common Stock?
The market capitalization of Certara, Inc. - Common Stock is 1.55B
How many shares of Certara, Inc. - Common Stock are outstanding?
Certara, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.